Guidance

Routine childhood immunisations from 1 July 2026

Updated 24 August 2026

Routine childhood immunisations

Age due	Diseases that vaccines protect against	Vaccine given	Trade name	Usual site[footnote 1]
Eight weeks old	Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B	DTaP/IPV/Hib/HepB (6 in 1 vaccine)	Infanrix hexa or Vaxelis	Thigh
	Meningococcal group B (MenB)	MenB	Bexsero	Thigh
	Rotavirus gastroenteritis	Rotavirus	Rotarix[footnote 2]	By mouth
Twelve weeks old	Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B	DTaP/IPV/Hib/HepB (6 in 1 vaccine)	Infanrix hexa or Vaxelis	Thigh
	MenB	MenB	Bexsero	Thigh
	Rotavirus	Rotavirus	Rotarix[footnote 2]	By mouth
Sixteen weeks old	Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B	DTaP/IPV/Hib/HepB (6 in 1 vaccine)	Infanrix hexa or Vaxelis	Thigh
	Pneumococcal (13 serotypes)	PCV	Prevenar 13	Thigh
One year old (on or after the child’s first birthday	Pneumococcal MenB Measles, mumps, rubella, varicella	PCV MenB MMRV	Prevenar 13 Bexsero ProQuad or Priorix Tetra	Upper arm or thigh
Eighteen months old	Born on or after 1 July 2024 Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B Measles, mumps, rubella, varicella Born on or before 30 June 2024 No appointment	DTaP/IPV/Hib/HepB MMRV	Infanrix hexa or Vaxelis ProQuad or Priorix Tetra	Upper arm or thigh
Three years four months old or soon after	Born on or after 1 January 2025 Diphtheria, tetanus, pertussis and polio Born on or before 31 December 2024 Diphtheria, tetanus, pertussis and polio Measles, mumps, rubella, varicella	dTaP/IPV MMRV	REPEVAX ProQuad or Priorix Tetra	Upper arm
Boys and girls aged twelve to thirteen years	Cancers and genital warts caused by specific human papillomavirus (HPV) types	HPV	Gardasil 9	Upper arm
Fourteen years old (school year 9)	Tetanus, diphtheria and polio	Td/IPV	REVAXIS	Upper arm
	Meningococcal groups A, C, W and Y	MenACWY	MenQuadfi	Upper arm
Eligible paediatric age group See annual flu letter	Influenza (each year from September)	LAIV (Live attenuated influenza vaccine) • If LAIV is contraindicated or otherwise unsuitable use inactivated flu vaccine (check Green Book Chapter 19 for details)	Fluenz (contains porcine gelatine)	Both nostrils

Selective immunisation programmes

Target group	Age and schedule	Disease	Vaccines required
Babies born to mothers with hepatitis B[footnote 3]	At birth and four weeks	Hepatitis B	Hepatitis B (Engerix B/HBvaxPRO)
Infants in areas of the country with TB incidence >= 40/100,000	Within 28 days of birth	Tuberculosis	BCG Check SCID screening outcome before giving BCG
Infants with a parent or grandparent born in a high incidence country[footnote 4]	Within 28 days of birth	Tuberculosis	BCG Check SCID screening outcome before giving BCG
Children in a clinical risk group	Age 6 months to under 2 years • if first ever flu vaccine give second dose at 4 weeks	Influenza	Inactivated flu vaccine
	Aged 2 to 8 years • if first ever flu vaccine give second dose at 4 weeks		LAIV • if LAIV contraindicated or otherwise unsuitable give inactivated flu
	Aged 9 to 17 years • only one dose required each flu season		LAIV • if LAIV contraindicated or otherwise unsuitable give inactivated flu
Pregnant women	At any stage of pregnancy during flu season	Influenza	Inactivated flu vaccine
	From 16 weeks gestation	Pertussis	Tdap (ADACEL) This vaccine given also provides protection against tetanus and diphtheria
	From 28 weeks gestation	RSV	RSV vaccine (Abrysvo)

1. Intramuscular injection into deltoid muscle in upper arm or anterolateral aspect of the thigh. ↩

2. Rotavirus vaccine should only be given after checking for SCID screening result. ↩ ↩²

3. Take blood for HBsAg anytime between 12 and 18 months to test for infection. In addition hexavalent vaccine (Infanrix hexa or Vaxelis) is given at 8, 12 and 16 weeks and also at 18 months. ↩

4. Where the annual incidence of TB is >= 40/100,000 – see tuberculosis by country ↩